Eli Lilly boss brands UK ‘worst country in Europe’ for cheap drug prices
Dave Ricks says Britain will miss out on medicines and future investment unless it pays more
Dave Ricks says Britain will miss out on medicines and future investment unless it pays more

US drugmaker wants changes to types of drugs approved in Britain

US pharmaceutical group ‘optimistic’ about reaching deal with British government

Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs

Ambassador’s meeting with chancellor Rachel Reeves came days before AstraZeneca and Merck paused projects in Britain

Life sciences should be a natural place to look for growth

Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines